© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Stachydrine hydrochloride started raising eyebrows among researchers once its main source, the herb Leonurus japonicus (commonly known as motherwort), made its presence known in both Eastern and Western traditional remedies. Looking back at the early 20th century, people relied on plant extracts to spark curiosity in chemical isolation. Experts in herbal medicine saw firsthand how teas brewed from motherwort brought relief in menstrual and cardiovascular complaints. Eventually, scientists began breaking down these botanical cocktails to identify active molecules, leading to the identification and subsequent isolation of stachydrine. Over time, scholars applied organic chemistry methods to isolate, purify, and finally characterize stachydrine hydrochloride. Its journey from folk remedy to lab-grade chemical mirrors the broader trend in pharmaceuticals: learning from the old, extracting what’s useful, and standardizing it for precision.
This compound, which goes by the name stachydrine hydrochloride, draws interest for its presence as a natural quaternary ammonium alkaloid. Folk healers once consumed it unwittingly, but today’s suppliers package it as a white crystalline solid. Researchers learned that isolating the hydrochloride salt form gets better water solubility. Pharmaceutical producers choose this format to improve dosing accuracy and shelf stability while keeping the product easy to handle. In practical terms, it’s mainly available in sealed glass vials or moisture-resistant packaging, labeled for either analytical or bulk industrial use. No longer lost in unmeasured herbal mixtures, stachydrine hydrochloride stands alone as a refined chemical with defined content, purity level, and purpose.
With a molecular formula of C7H14ClNO2 and a molar mass around 179.64 g/mol, stachydrine hydrochloride has a high melting point (usually recorded between 235-239°C). Its crystalline structure makes contamination visible, so even small impurities stick out. Its solubility in water, versus only moderate solubility in alcohols, helps chemists design injectables and oral preparations. Strict pH limits make it sensitive to basic or acidic environments, which makes sense given its origins as a plant alkaloid. As a quaternary ammonium salt, it resists breakdown under routine storage but doesn’t stand up to strong oxidizers. This stability wins points for industrial handling, provided companies keep it away from reactive chemicals or excessive moisture.
When examining technical sheets, pharmaceutical and lab suppliers set specifications for stachydrine hydrochloride, including purity of at least 98%, water content below 2%, and defined levels for related alkaloids. Labels display the chemical abstract number (CAS 251-37-2), appropriate hazard warnings (such as respiratory irritation or eye sensitivity), and basic first-aid information based on Globally Harmonized System (GHS) standards. They also include recommended storage: keep it at room temperature, away from light and humidity, and use desiccants where possible. Behind the barcode and product batch code, the company stands ready to respond to any recall, reflecting growing consumer expectations for accountability and transparency in every chemical lot.
Early approaches to stachydrine hydrochloride extraction relied on a simple water or ethanol soak to pull the alkaloid from the crushed motherwort plant. Modern methods ditch crude decoction in favor of pressurized extraction or column chromatography, using ion exchange resins and controlled pH to clean up the isolate. Once separated, conversion into the hydrochloride salt involves bubbling dry HCl gas through the solution, followed by recrystallization to enhance purity. Tight quality controls ensure minimal contamination; experienced technicians spend hours monitoring temperature, solvent pH, and filtration rates. This extra diligence means a more consistent, market-ready product, which ultimately means safer outcomes downstream.
Stachydrine hydrochloride brings a rarely reactive, yet versatile, quaternary ammonium core. Despite this chemical stubbornness, exposure to strong acids shifts the salt balance, producing stachydrine base and releasing hydrochloric acid gas. Mild alkali breaks down the hydrochloride salt, raising possible issues for certain formulations. Researchers experimenting with chemical modifications focus on transforming the methyl group or lengthening the alkyl chain—sometimes hoping these tweaks will yield new pharmacological effects. In synthetic labs, derivatization techniques push the boundaries of the molecule’s utility, generating analogs for receptor binding studies or pharmacokinetic runs. For most practical uses, though, pure stachydrine hydrochloride stays unchanged.
On the market, stachydrine hydrochloride appears under various guises. The pharmaceutical community frequently refers to it by its IUPAC name, proline betaine hydrochloride. In older herbal texts, “stachydrine” implies the naturally occurring base, but the hydrochloride form gets used for its better solubility. Alternate names like “Leonurus alkaloid” or “motherwortine hydrochloride” appear in local product catalogs or academic literature from Asia and Europe. Such variation complicates regulatory efforts, occasionally triggering customs or import questions as different synonyms pop up on shipping manifests. For those tracking down safety data, knowing each alias becomes as important as understanding the molecule itself.
Working hands-on with stachydrine hydrochloride, lab staff receive training on safe material transfer, personal protective equipment (PPE), and correct incident response protocols. Dust can be irritating—a face mask and gloves keep inhalation and accidental skin absorption at bay. Manufacturers set internal exposure limits to reflect oral and dermal absorption studies; these usually align with established guidelines for many water-soluble quaternary ammonium salts. In regulated facilities, Material Safety Data Sheets (MSDS) hang on the wall, and spill kits line every bench. Disposal follows environmental protection agency (EPA) or equivalent directives: dilute and neutralize the residue, then send it for destruction as non-hazardous waste barring bulk chemical contamination. Every step aims to protect workers and the surrounding environment.
Pharmaceutical developers test stachydrine hydrochloride for its cardiovascular and uterotonic activity given its origins in motherwort, exploring whether its muscle-relaxing properties translate from folk tales to standard care. Clinical pharmacology studies with animal and early human models checked its impact on blood flow, uterine contraction, and inflammation. In the wider nutraceutical sector, manufacturers use it to enrich extracts in tablet and powder supplements designed for circulatory health. Analytical chemistry researchers use stachydrine as an internal standard for plant alkaloid quantification, especially in complex herbal tinctures. Its unique structure draws attention among those cataloging new bioactive metabolites for drug discovery. Hospitals and specialty clinics still use, at times under supervision, herbal preparations high in stachydrine to address menstrual and vascular complaints.
Over the last two decades, research teams have launched a series of cellular and animal model studies probing stachydrine hydrochloride’s mechanisms. Results point toward endothelial protective effects, down-regulation of oxidative stress, and even modulation of fibrosis in select models. Researchers continue to refine extraction from alternative plant sources, not just motherwort but also citrus byproducts, showcasing an industry-wide shift toward sustainable sourcing. Interest has grown in formulating improved derivatives with enhanced blood-brain barrier penetration, broadening possible uses in neuroprotection. As stachydrine hydrochloride transitions from a secondary player in herbal medicine to an active target for drug discovery, new academic partnerships spring up between botanists, synthetic chemists, and pharmacologists to push understanding further. The necessity of replicable results, combined with strict regulatory requirements, ensures research stays grounded in evidence, not hype.
Early bioassays and animal testing indicated that stachydrine hydrochloride has a favorable safety margin at recommended therapeutic doses. Dosing rats and mice at several-fold human equivalent levels showed little acute toxicity—lethargy or soft stool, but no lethal events. Longer term intake at supra-physiological doses produced no evidence of liver or kidney toxicity in most published studies, although some confidential industrial research still holds out for new findings. Reproductive and mutagenicity screens, required for any pharmaceutical hope, flagged no concerning effects on embryo implantation or chromosomal structure at relevant dosages. Clinical pharmacologists warn daily about potential idiosyncratic sensitivity, so clinical trials in humans (especially in pregnancy) run under close physician supervision. Government agencies keep an eye on new safety data, waiting for independent verification before easing restrictions on new uses.
Looking ahead, stachydrine hydrochloride could act as a bridge between plant-based remedies and modern therapies for cardiovascular, reproductive, or fibrotic diseases. Biotech companies seek ways to engineer scalable, eco-friendly production—either through genetically modified plants or microbial fermentation that spits out the alkaloid at industrial scale, slashing costs and easing environmental impact. Formulators experiment with cyclodextrin complexes and nanoencapsulation to increase absorption and reduce dosing frequency. Regulatory authorities will demand well-designed clinical trials proving safety and efficacy before approving new claims or indications, echoing past lessons learned from both synthetic and botanical product launches. If ongoing research continues to uncover real benefit, stachydrine hydrochloride could carve out a niche in prescription drugs, over-the-counter supplements, or even topical skin and eye treatments. Staying grounded in science, not just promising theory, will separate passing trend from long-term staple.
Stachydrine hydrochloride isn’t the sort of name that rolls off the tongue, and most folks haven’t heard of it unless they’ve dug into pharmacology or traditional Chinese medicine. It comes from the Chinese motherwort plant, known as Leonurus japonicus, which has a long track record in herbal remedies. For years, it’s been part of the toolkit for treating women’s health issues, especially problems connected to menstruation and childbirth. Even before researchers could explain its actions with chemistry, people saw its effects in the real world.
Today, stachydrine hydrochloride is still connected to those same roots. Doctors and herbalists in several countries look to it for its ability to improve blood flow and help the uterus work more efficiently. In places where herbal medicine stands side by side with pharmaceuticals, it often lands in prescriptions for “blood stasis”—a catch-all term that covers everything from irregular periods to postpartum recovery.
Over the past few decades, more studies have tried to shine a light on exactly how stachydrine hydrochloride supports health. Research shows that it can help dilate blood vessels and reduce blood pressure, which takes some pressure off the heart. I’ve seen cardiovascular specialists in China talk about how patients with early heart failure sometimes benefit from stachydrine as an add-on to standard medicine. One study published in the Journal of Ethnopharmacology reported that it promotes circulation and might reduce the risk of dangerous clots.
A lot of excitement also comes from how this compound interacts with inflammation. Chronic inflammation makes almost every disease worse, especially heart disease and diabetes. Some evidence suggests that stachydrine hydrochloride can tamp down some of that inflammation in animal experiments. Scientists see encouraging signs, but human trials haven’t caught up yet.
Not every researcher buys into the hype. Western medicine doesn’t hand out gold stars to compounds until they’ve cleared big clinical trial hurdles. So far, most of the data comes from lab studies and small groups of people. That gap between tradition and rock-solid proof causes friction. As someone who’s tried herbal remedies and spent time in hospitals, I see the tension between patients who want more options and doctors who follow strict guidelines.
Everything strong enough to help health has the power to cause side effects. Stachydrine hydrochloride isn’t as gentle as peppermint tea. Some reports describe nausea, dizziness, and allergic reactions, usually in people who took high doses or mixed it with other drugs. For women with heavy menstrual bleeding, too much can make matters worse. Pharmacists in community clinics emphasize that patients should be open with all members of their care team before starting any supplements.
Scientists are working to figure out the best uses and safest doses. Finding out who truly benefits from stachydrine hydrochloride calls for clear studies on real patients. Regulatory agencies want to see solid evidence before recommending any herb-based medicines as mainstream treatments. I believe open-mindedness and caution need to go hand in hand, both for patients searching for relief and for the doctors trying to help them.
What stands clear: stachydrine hydrochloride has caught the attention of practitioners and researchers for a reason. It sits at the intersection of tradition and modern science—offering hope where little relief exists and challenging us to learn more before making any promises.
Stachydrine hydrochloride comes from plants like Chinese motherwort. Herbalists and researchers have looked at this compound for decades, drawn by stories of mothers who relied on it after childbirth. The most interesting thing about it: it hasn’t faded into obscurity as many traditional plant remedies have. Modern scientists are digging up evidence that supports what folk medicine talked about all along.
Cardiovascular wellness drives a lot of current research on stachydrine. Some labs found it can relax smooth muscle tissue, which affects blood flow and pressure. One study from 2015, published in Phytomedicine, saw stachydrine support healthy blood pressure in rats without hurting organ function. Anyone with family history of blood pressure issues knows the value of support options that don’t pile on new side effects.
Growing up, I watched my grandmother turn to herbal teas during tough periods and after childbirth. Stachydrine isn’t new for those looking for relief from cramps or hormonal swings. Traditional Chinese medicine uses it for better blood circulation and to ease discomfort after childbirth. Recent studies back up these customs, showing the compound influences uterine muscle contractions. One paper in the Journal of Ethnopharmacology points to a gentle support role—making those post-partum weeks a bit easier.
Body aches and swelling come for everyone at some point. Researchers have tested stachydrine’s anti-inflammatory properties, especially in chronic conditions. Experiments in cell cultures and animal models suggest lowered inflammation markers after taking the compound. These results open doors for more natural approaches to long-term ache management. While more human research needs to be done, folks with chronic pain conditions keep their eyes on any new option that won’t mess with their stomach or leave them foggy.
Blood flow to the kidneys matters for filtering waste and keeping blood pressure in a healthy range. Stachydrine seems to protect these organs under stress, at least in animal experiments. A 2021 study in the journal Drug Design, Development and Therapy found stachydrine shields kidney cells from damage tied to diabetes and high blood pressure. Those actions might give doctors and patients options that work alongside mainstream medicine.
Like any plant extract, quality differs depending on how it’s grown and processed. Too few studies have checked stachydrine in humans to give clear dosing guidance or guarantee safety. Herbal supplements aren’t magic bullets but can fit into a bigger plan for wellness—if people talk openly with their healthcare team. Trust only brands that share testing results on purity and source. If doctors and patients work together, plant compounds like stachydrine might find a proper place in everyday health.
Most folks searching for natural remedies may have come across stachydrine hydrochloride, usually sourced from motherwort. In traditional medicine, stachydrine carries a lot of history. Some people hope it could help with blood flow, period pain, or high blood pressure. Researchers saw some promise in early lab findings, but anyone thinking about trying it wonders: Is it safe? Are there any side effects?
I’ve worked with plenty of people who trust herbs and natural products to support their health. Sometimes, folks believe “natural” equals “no risk,” but that isn’t always true. Even common kitchen herbs can cause nausea, diarrhea, or headaches if taken in big amounts or combined with prescription drugs. I’ve seen people forget to talk to their doctor and end up feeling worse—a reminder that understanding side effects matters.
Stachydrine hydrochloride doesn’t show up in most modern pharmacies, and clinical studies in people are limited. Some research in animals and cells suggests stachydrine impacts blood pressure, heart rhythm, and uterine muscle contractions. In theory, these actions could present risks like dizziness, low blood pressure, or stomach upset—especially for people already managing hypertension, heart problems, or pregnancy.
Data on how it interacts with prescription medications stays spotty. If you take blood thinners, heart meds, or anything affecting hormones, adding stachydrine seems risky without a healthcare professional’s input. Some case reports mention possible allergic reactions: rashes, itching, or even trouble breathing. These aren’t common, but the risk jumps up in folks with a history of allergies to plants in the mint family.
Pregnant women have extra reason to be cautious. I’ve found that many herbalists warn against using motherwort and its extracts during pregnancy. The reason comes from its possible action on uterine muscles, which could put pregnancy at risk. Even outside of pregnancy, older adults or those on several medications could face complications—herbs aren’t always gentle companions.
Relying on solid science before adding any supplement makes sense. Unfortunately, stachydrine hydrochloride hasn’t gathered the kind of evidence that earns trust across the board. As someone who’s watched friends and family reach for herbal pills, I always tell them to look for quality control, clear labels, and doctor guidance—especially with rare supplements.
We need more clinical trials in real people and less Internet hype. Doctors and pharmacists can help people check for drug interactions and side effects specific to their own bodies. Regulators should also require more transparency for supplements: clear ingredient lists and proven batch testing. If your health feels off after trying something new, mention it to your doctor. Don’t shrug it off. Sharing your story might protect someone else down the road.
Stachydrine hydrochloride might look promising, but short-term trends can’t beat steady, evidence-backed health habits. For now, making room for honest conversations with health professionals stays the safest path.
Figuring out how much Stachydrine Hydrochloride someone should take is not as simple as pulling a number out of a pharmacology textbook. There’s never a one-size-fits-all answer, especially since this compound hasn’t been mainstream in places like the US or Europe. In China, Stachydrine Hydrochloride has a history in both modern and traditional medicine, mainly for circulatory health or gynecological issues. Most clinical resources and reviews point to dosages hovering between 30 mg and 60 mg daily for adults, given in divided doses. Actual prescriptions depend on the specific condition they’re tackling, age, weight, and whether someone is dealing with kidney or liver concerns.
In practice, getting dosage right makes the difference between real benefit and unnecessary risk. I’ve seen too many people assume natural plant compounds can’t cause problems. Stachydrine Hydrochloride, usually pulled out of Leonurus japonicus, may be “natural,” but it has real pharmacological effects. Taking more than what a doctor recommends can push blood pressure too low, sometimes cause palpitations, or send someone running to the bathroom. Skipping doctor guidance sometimes leads to messy outcomes.
Researchers have gone through trials focusing on heart and uterine conditions, summarizing information in meta-analyses published by journals like the Journal of Ethnopharmacology. Most studies land at 30–60 mg daily, orally, for adults. In some reports, doses creep up toward 90 mg per day for short bursts, but longer-term use tends to keep to the lower end. Long-standing Chinese Pharmacopoeia guidelines back up these numbers.
Every supplement carries a downside if ignored. People with existing heart rhythm issues or chronic hypotension shouldn’t try Stachydrine Hydrochloride on a whim. Kidney and liver patients face extra uncertainty because the body clears chemicals more slowly. Mixed with prescribed anticoagulants, there’s always a risk of bleeding complications. I once watched a patient end up dizzy and weak after adding herbal extracts on advice from a friend. That hard lesson drives home how important clear, professional dosing advice really is.
Pharmacists and medical professionals stress lab-tested batches and product traceability, especially for less-common chemicals. Checking for contamination or mislabeling remains key. Always searching for verified manufacturers—those who publish third-party test results—can sidestep nasty surprises. Patients can talk through any drug interactions or risks before adding supplements, instead of reacting after a problem pops up.
Making dosing guidelines accessible takes strong cooperation between doctors, pharmacists, and researchers. Patient education needs honest conversations—what works, what’s unproven, and what’s outright dangerous. If someone is interested in Stachydrine Hydrochloride for longstanding health issues, nothing beats medical supervision. Routine checkups, drug monitoring, and blood pressure tracking bring much more peace of mind than online forum guesses or influencer recommendations.
Using any active compound—natural or synthetic—should always build on well-documented clinical evidence. People deserve transparency about what’s in their supplements, how much to take, and what to watch for. Following established dosage guidelines for Stachydrine Hydrochloride, sharing open channels of communication with health providers, and putting safety at the center keeps both science and personal health moving forward.
Stachydrine hydrochloride keeps popping up in online wellness circles. Marketed as a natural supplement, it comes from Chinese motherwort and citrus fruits. Some websites claim it's helpful for blood circulation, heart health, and liver protection. It sounds promising, almost too good to ignore. Still, new compounds can ride into the spotlight with more hype than evidence. My own approach to new supplements: Look for studies, not stories.
Researchers have paid attention to stachydrine for its heart health effects. A paper from 2022 in “Frontiers in Pharmacology” covered laboratory research showing stachydrine may protect vascular lining or “endothelial” cells from injury. Some animal studies went a step further, hinting it could lower blood pressure or help fight heart muscle damage after a heart attack. You won’t find anything close to the evidence that exists for medications doctors prescribe daily.
Long-term safety remains unexplored. Clinical trials on people barely exist. No published, peer-reviewed research has documented what happens if a person takes stachydrine every day for months or years. There’s also little information about interactions with medication. Websites and spoon-fed supplement guides often gloss over this gap. Anyone who has seen an online hype train for something like this knows the gap between a promising chemical and a proven long-term remedy can be wide.
Many assume “natural” means safe. It doesn’t work that way, and the history books are full of natural compounds gone wrong. Digitalis, derived from foxglove, once helped hearts but caused plenty of poisonings. Some herbs have cost athletes a spot in the Olympics. Even caffeine, a plant chemical, lands people in the ER each year. I have seen patients bring in their supplement bottles asking if their new “miracle extract” might mess with blood thinners or cholesterol drugs. Doctors rarely have answers for rare compounds, and that leaves regular people guessing.
Nobody tests supplements for safety on the scale reserved for prescription drugs. The FDA doesn’t review supplements like it reviews medicines. Laws expect companies to sell safe products but don’t demand rigorous safety data before shelving them. A supplement can hit online markets and only face pushback if people report harm.
Long-term use of stachydrine hydrochloride must be called uncertain—almost a black box from a safety perspective. Some documented short-term side effects include nausea or heartburn. Anything that causes mild problems in a short window could reveal bigger risks after sustained exposure. Any person taking blood pressure meds, blood thinners, or dealing with chronic illness should be cautious about adding unfamiliar supplements.
Anybody interested in trialing a supplement like stachydrine hydrochloride should look for transparent manufacturers, avoid any “cure-all” promises, and discuss plans with a knowledgeable healthcare provider. Real safety for the long haul requires clinical trials that follow people, document side effects, and measure risk both high and low.
We all want safer, better tools for good health. But every generation learns, sometimes the hard way, that promising shortcuts don’t always lead where we hope. For now, stachydrine’s promise remains an open question—and deserves a cautious, watchful eye.
| Names | |
| Preferred IUPAC name | 1-carboxy-N,N-dimethylpyrrolidinium-2-ium chloride |
| Other names |
Stachydrine HCl Proline betaine hydrochloride N,N-Dimethylproline hydrochloride N-Methylproline betaine hydrochloride |
| Pronunciation | /ˈstæ.kɪd.raɪn haɪˌdrɒk.ləˈraɪd/ |
| Identifiers | |
| CAS Number | 589-10-6 |
| 3D model (JSmol) | `3D model (JSmol)` string for **Stachydrine Hydrochloride**: ``` CC[N+](C)(C)CC(=O)O.[Cl-] ``` |
| Beilstein Reference | 126122 |
| ChEBI | CHEBI:4890 |
| ChEMBL | CHEMBL444179 |
| ChemSpider | 11313 |
| DrugBank | DB04208 |
| ECHA InfoCard | 100.130.709 |
| EC Number | EC 224-662-8 |
| Gmelin Reference | 77158 |
| KEGG | C10225 |
| MeSH | D017900 |
| PubChem CID | 11593 |
| RTECS number | SY8575000 |
| UNII | 065C09943M |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C7H14ClNO2 |
| Molar mass | 207.68 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.22 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -2.49 |
| Acidity (pKa) | 10.24 |
| Basicity (pKb) | 4.15 |
| Magnetic susceptibility (χ) | -39.5e-6 cm³/mol |
| Dipole moment | 2.74 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 247.6 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | C01DX15 |
| Hazards | |
| Main hazards | Causes skin irritation, causes serious eye irritation, may cause respiratory irritation |
| GHS labelling | GHS02,GHS07 |
| Pictograms | ⚠️🧪 |
| Signal word | Warning |
| Hazard statements | No Hazard Statements |
| Precautionary statements | Wash hands thoroughly after handling. |
| Flash point | 163.7 °C |
| Lethal dose or concentration | LD₅₀ (mouse, intravenous): 44 mg/kg |
| LD50 (median dose) | LD50: 1,960 mg/kg (mouse, oral) |
| NIOSH | Not Listed |
| PEL (Permissible) | Not established |
| REL (Recommended) | 10 mM in DMSO |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Proline Hydroxyproline L-Proline hydrochloride N-Methylproline Betaines |
